Literature DB >> 11602671

Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.

K A Berg1, B D Stout, S Maayani, W P Clarke.   

Abstract

The serotonin (5-HT)2A and 5-HT2C receptors share a high degree of sequence homology and have very similar pharmacological profiles. Although it is generally believed that the cellular signal transduction mechanisms activated by these receptors are indistinguishable, recent data suggest significant differences in their signaling cascades. In this study we explored differences in the characteristics and mechanisms of rapid desensitization between the 5-HT2A and 5-HT2C receptor systems. For both receptor systems, pretreatment with 5-HT reduced the ability of a maximal concentration of 5-HT to stimulate phospholipase C-mediated inositol phosphate accumulation by about 65%, although the 5-HT2C receptor system was more sensitive to the desensitizing stimulus. Differences in the concentration dependence of the rate constant for desensitization (k(des)) suggested different mechanisms of desensitization for the 5-HT2A and 5-HT2C receptor systems. At very high receptor occupancy (>99%), the responsiveness of the 5-HT2A, but not the 5-HT2C, receptor system returned to control levels despite the continued presence of the agonist. This resensitization was dependent upon the activity of protein kinase C (PKC). Agonist-induced desensitization of the 5-HT2A, but not the 5-HT2C, receptor system was reduced by the PKC inhibitors staurosporine and bisindolylmaleimide, and by down-regulation of PKC. In addition, inhibitors of calmodulin (W-7) or of calmodulin-dependent protein kinase II, reduced 5-HT2A, but not 5-HT2C, desensitization. Desensitization of the 5-HT2C, but not the 5-HT2A, receptor system was dependent on G protein receptor kinase activity. These data further emphasize the major differences in the signaling systems coupled to 5-HT2A/2C receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602671

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  24 in total

1.  Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex.

Authors:  Noelle C Anastasio; Maria Fe Lanfranco; Marcy J Bubar; Patricia K Seitz; Sonja J Stutz; Andrew G McGinnis; Cheryl S Watson; Kathryn A Cunningham
Journal:  J Neurochem       Date:  2010-03-24       Impact factor: 5.372

2.  Atypical antipsychotics and inverse agonism at 5-HT2 receptors.

Authors:  Laura C Sullivan; William P Clarke; Kelly A Berg
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

3.  Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability.

Authors:  Sophie Gavarini; Carine Bécamel; Christophe Altier; Philippe Lory; Joël Poncet; Jan Wijnholds; Joël Bockaert; Philippe Marin
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

4.  ERK Is a Critical Regulator of JC Polyomavirus Infection.

Authors:  Jeanne K DuShane; Michael P Wilczek; Colleen L Mayberry; Melissa S Maginnis
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

5.  Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.

Authors:  B Schaerlinger; P Hickel; N Etienne; L Guesnier; L Maroteaux
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

6.  Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2.

Authors:  Rémi Bos; Karina Sadlaoud; Pascale Boulenguez; Dorothée Buttigieg; Sylvie Liabeuf; Cécile Brocard; Georg Haase; Hélène Bras; Laurent Vinay
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

7.  Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.

Authors:  M J Enguix; L Sánchez; M Villazón; J Brea; H Tristán; H J Caruncho; M I Cadavid; M I Loza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-12       Impact factor: 3.000

8.  Novel Bivalent 5-HT2A Receptor Antagonists Exhibit High Affinity and Potency in Vitro and Efficacy in Vivo.

Authors:  Claudia A Soto; Matthew J Shashack; Robert G Fox; Marcy J Bubar; Kenner C Rice; Cheryl S Watson; Kathryn A Cunningham; Scott R Gilbertson; Noelle C Anastasio
Journal:  ACS Chem Neurosci       Date:  2017-11-21       Impact factor: 4.418

9.  Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior.

Authors:  Noelle C Anastasio; Scott R Gilbertson; Marcy J Bubar; Anton Agarkov; Sonja J Stutz; Yowjiun Jeng; Nicole M Bremer; Thressa D Smith; Robert G Fox; Sarah E Swinford; Patricia K Seitz; Marc N Charendoff; John W Craft; Fernanda M Laezza; Cheryl S Watson; James M Briggs; Kathryn A Cunningham
Journal:  J Neurosci       Date:  2013-01-23       Impact factor: 6.167

10.  Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signaling.

Authors:  Ryan T Strachan; Douglas J Sheffler; Belinda Willard; Michael Kinter; Janna G Kiselar; Bryan L Roth
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.